Advanced Medical Solutions Group plc (LON:AMS – Get Free Report)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 213.38 and traded as low as GBX 193.80. Advanced Medical Solutions Group shares last traded at GBX 196.03, with a volume of 680,553 shares traded.
Analyst Ratings Changes
Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 300 price target on shares of Advanced Medical Solutions Group in a research report on Wednesday, March 18th. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of GBX 273.67.
Get Our Latest Stock Analysis on AMS
Advanced Medical Solutions Group Price Performance
Advanced Medical Solutions Group (LON:AMS – Get Free Report) last issued its quarterly earnings data on Wednesday, March 18th. The company reported GBX 11.98 earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a return on equity of 3.87% and a net margin of 4.35%. Research analysts forecast that Advanced Medical Solutions Group plc will post 9.8159509 earnings per share for the current year.
About Advanced Medical Solutions Group
AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.
Further Reading
Receive News & Ratings for Advanced Medical Solutions Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Solutions Group and related companies with MarketBeat.com's FREE daily email newsletter.
